NDC 0469-2660 – Veozah

Fezolinetant 45 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC0469-2660

Product details

Brand name
Veozah
Generic name
Fezolinetant
Labeler
Astellas Pharma US, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA216578
Marketed since
May 12, 2023
Listing expires
December 31, 2027
Pharmacologic class
Neurokinin 3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Veozah →

Package NDC codes (2)

Package NDCDescriptionSince
0469-2660-301 BOTTLE in 1 CARTON (0469-2660-30) / 30 TABLET, FILM COATED in 1 BOTTLEMay 12, 2023
0469-2660-901 BOTTLE in 1 CARTON (0469-2660-90) / 90 TABLET, FILM COATED in 1 BOTTLEMay 12, 2023

Other Veozah products